Key result
Cilostazol was evaluated for its effects in patients with high residual platelet reactivity after drug-eluting stent implantation.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eleonora et al. (2024) studied this question. Cilostazol was evaluated for its effects in patients with high residual platelet reactivity after drug-eluting stent implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: